Buprenorphine is a partial mu-opioid receptor agonist and the most widely used opioid analgesic in feline medicine. It is considered the opioid of choice for mild to moderate pain in cats due to its excellent efficacy, wide safety margin, favorable pharmacokinetics in the feline species, and unique ability to be absorbed through the oral mucosa (oral transmucosal or OTM route) in cats. Simbadol is an FDA-approved, concentrated formulation of buprenorphine specifically designed for subcutaneous use in cats.
Overview
Cats present unique pharmacological challenges for pain management. Many common analgesics used in dogs are poorly tolerated or dangerous in cats due to the feline deficiency in hepatic glucuronidation — the major metabolic pathway for many drugs including NSAIDs and certain opioids. Buprenorphine is an excellent choice for cats because it undergoes significant metabolism through pathways other than glucuronidation, providing predictable analgesic effects without the toxicity risks seen with other drugs.
A key advantage of buprenorphine in cats is its oral transmucosal (OTM) absorption. The feline mouth has an alkaline pH (approximately 8.0 to 9.0), which favors absorption of buprenorphine (a weak base) across the oral mucosa. This allows cat owners to administer the drug by placing it inside the cheek pouch, avoiding the stress of injections at home. OTM bioavailability in cats is approximately 50 percent, far higher than in dogs or humans.
Uses
- Post-surgical pain: Standard analgesic for spays, neuters, dental procedures, and orthopedic surgeries.
- Acute pain: Trauma, injury, urethral obstruction, pancreatitis, and other acute painful conditions.
- Moderate chronic pain: May be used short-term for conditions like oral pain, stomatitis, or cancer-related discomfort.
- Hospitalized patients: Commonly administered in veterinary hospitals for perioperative pain management.
- Simbadol: FDA-approved for 24-hour pain control via a single subcutaneous injection in cats.
Dosage
| Parameter | Detail |
|---|---|
| OTM dose (standard buprenorphine) | 0.01–0.03 mg/kg applied to oral mucosa every 6–8 hours |
| Injectable dose | 0.01–0.03 mg/kg IV, IM, or SC every 6–8 hours |
| Simbadol (1.8 mg/mL) | 0.24 mg/kg SC once daily for up to 3 days |
| Standard concentration | 0.3 mg/mL (Buprenex) |
| Simbadol concentration | 1.8 mg/mL (do NOT use Simbadol OTM) |
| Onset (OTM) | 30–45 minutes |
| Onset (injectable) | 15–30 minutes |
| Duration | 6–8 hours (standard); up to 24 hours (Simbadol) |
Important dosing notes:
- For OTM administration, use the standard 0.3 mg/mL concentration only. Place the measured dose into the cheek pouch using a syringe (without a needle). Do not let the cat swallow it — oral mucosal absorption is the goal.
- Simbadol (1.8 mg/mL) is for subcutaneous injection only and should NOT be given OTM, as the concentrated formulation and volume are not designed for transmucosal use.
- Do not exceed 3 consecutive days of Simbadol without veterinary reassessment.
- Buprenorphine has a ceiling effect: increasing the dose beyond a certain point does not increase analgesia.
Side Effects
| Common Side Effects | Serious Side Effects (Contact Your Vet) |
|---|---|
| Mild sedation | Significant respiratory depression (rare at standard doses) |
| Dilated pupils (mydriasis) | Severe sedation or unresponsiveness |
| Euphoria or purring | Difficulty breathing |
| Mild decrease in appetite | Hypothermia |
| Mild hypersalivation (OTM route) | Signs of allergic reaction |
Buprenorphine has a wide safety margin in cats. As a partial agonist, it has a ceiling effect on respiratory depression, making it safer than full mu-agonists like morphine or fentanyl.
Drug Interactions
- Full mu-opioid agonists (morphine, fentanyl, hydromorphone): Buprenorphine may partially block the effects of full agonists due to its high receptor affinity. Avoid concurrent use or allow adequate washout.
- Benzodiazepines (midazolam, diazepam): Additive sedation; often combined intentionally in veterinary settings but monitor respiratory function.
- Other CNS depressants: Additive sedation risk.
- MAO inhibitors (selegiline): Potential for serious interactions; avoid concurrent use.
- Acepromazine: Additive sedation; commonly combined at reduced doses in veterinary protocols.
Contraindications
- Do not use in cats with known hypersensitivity to buprenorphine.
- Use with caution in cats with severe hepatic disease.
- Use with caution in cats with significant respiratory compromise.
- Do not use Simbadol in cats under 2.6 pounds (1.2 kg) body weight.
- Safety in pregnant or lactating cats has not been fully evaluated.
Storage
- Store at room temperature (68–77 degrees F / 20–25 degrees C).
- Protect from prolonged exposure to light.
- Buprenorphine is a Schedule III controlled substance; store securely.
- Keep out of reach of children and pets.
FAQ
Q: Why is buprenorphine considered the best opioid for cats? A: Buprenorphine is ideal for cats because of its excellent OTM absorption (due to feline alkaline oral pH), wide safety margin, ceiling effect on respiratory depression, and metabolism through pathways that cats handle well. Cats have limited glucuronidation capacity, which makes many other drugs (including some opioids and NSAIDs) risky, but buprenorphine is not significantly affected by this limitation.
Q: How do I give buprenorphine OTM to my cat at home? A: Using the syringe provided by your veterinarian, gently lift your cat’s lip and slowly deposit the measured dose into the cheek pouch between the gum and cheek. Do not squirt it onto the tongue or down the throat — the drug needs contact with the oral mucosa to be absorbed. Most cats tolerate this well, especially when calm.
Q: What is the difference between Simbadol and regular buprenorphine? A: Simbadol is a concentrated (1.8 mg/mL) formulation designed for once-daily subcutaneous injection, providing 24 hours of pain relief. Standard buprenorphine (0.3 mg/mL) requires dosing every 6 to 8 hours and can be given by multiple routes including OTM. Simbadol should only be given by subcutaneous injection.
Q: Can buprenorphine be used long-term in cats? A: Buprenorphine is primarily used for acute pain management (days to a couple of weeks). Long-term opioid use in cats is generally not recommended without ongoing veterinary supervision due to the potential for tolerance and the availability of better long-term pain management strategies.
This content is for informational purposes only and is not a substitute for professional veterinary advice. Always consult your veterinarian before starting, changing, or stopping any medication for your cat.